Alexandra Glucksmann
CIK: 0001658390
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RGNX
REGENXBIO Inc.
Director
Discretionary Trading P&L
Holdings
About Glucksmann Alexandra
Glucksmann Alexandra (SEC CIK 0001658390) files insider reports with the SEC as Director of REGENXBIO Inc. (RGNX).
Signal8 holds 2 ownership filings by Glucksmann Alexandra, all Form 4s, filed between Jun 3, 2025 and Jun 2, 2026. Those filings report 2 transactions, from May 30, 2025 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Glucksmann Alexandra's filings is in ROCKVILLE, MD.
Recent filings by Glucksmann Alexandra
Other insiders filing for REGENXBIO Inc. (RGNX)
- Malzahn Craig, Chief Technology Officer
- Christmas Patrick J., Chief Strategy & Legal Officer
- PAKOLA STEVE, Chief Medical Officer
- Chan Mitchell, Chief Financial Officer
- Ciongoli Gregory Austin, Director
- Simpson Curran, Chief Executive Officer